Logo Logo
Switch Language to German
Tiseo, M.; Huber, R. M.; Hochmair, M. J.; Bazhenova, L. A.; Ou, S.-H. I.; Reichmann, W.; Haney, J.; Kerstein, D.; Camidge, D. R.; Gettinger, S. N. (2017): Brigatinib in ALK plus NSCLC pts with intracranial CNS metastases in 2 clinical trials. In: Annals of Oncology, Vol. 28
Full text not available from 'Open Access LMU'.